iCHART Intervention for Teen Suicidal Behavior
Trial Summary
What is the purpose of this trial?
This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, anhedonia, and stress related to cybervictimization. This study will recruit 900 adolescents which will be enrolled in a randomized controlled trial to test iCHART and will be randomized to iCHART or treatment as usual (TAU). Based on previous work, the investigators hypothesize that iCHART, compared to TAU, will decrease suicidal-related events by 50%, and the effects will be mediated by increases in referrals, treatment engagement, and safety planning. The investigators will use implementation science methods to assess contextual factors (i.e., barriers and facilitators) and implementation outcomes specifically, acceptability, feasibility, appropriateness, and cost for our predictive algorithm and iCHART to inform future implementation efforts and promote health equity.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the iCHART treatment for teen suicidal behavior?
Research on similar interventions, like the Collaborative Assessment and Management of Suicidality (CAMS) for teens, shows promise in reducing suicidal thoughts and behaviors. These interventions are found to be acceptable and feasible, with preliminary results indicating a significant reduction in suicidal thoughts, suggesting that iCHART could be effective in a similar way.12345
Is the iCHART intervention for teen suicidal behavior safe for humans?
How is the iCHART treatment different from other treatments for teen suicidal behavior?
The iCHART treatment is unique because it integrates care specifically designed to help at-risk teens by focusing on understanding the emotional distress and interpersonal issues that contribute to suicidal behavior, and it includes intensive weekly sessions followed by email follow-up, which is not commonly found in standard care.19101112
Research Team
Stephanie Stepp, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for English-speaking teens aged 12-18 with depression or suicidal behavior, and their parents who are over 18 and speak English. Teens must have had recent suicidal thoughts or a history of attempts. Parents need to be biological/adoptive or legal guardians. Teens with severe mental conditions, life-threatening medical issues, intellectual disabilities, or without access to a phone/tablet are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are enrolled in the iCHART intervention or Treatment As Usual (TAU) to test the effectiveness in reducing suicide-related events
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of suicidal ideation and behavior
Treatment Details
Interventions
- iCHART (Behavioral Intervention)
- Treatment As Usual (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
University of Oregon
Collaborator
Columbia University
Collaborator
Children's Hospital of Philadelphia
Collaborator
Kaiser Permanente
Collaborator
National Institute of Mental Health (NIMH)
Collaborator